Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-3 of 3
Keywords: Adenosine deaminase
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Pharmacology
Journal:
Pharmacology
Pharmacology (1994) 48 (4): 265–272.
Published Online: 10 June 2008
... (EHNA), an inhibitor of adenosine deaminase, also potentiated the increased concentrations of adenosine in venous blood by 6-fold and raised arterial adenosine concentrations by 3-fold. Pretreatment with combination of dilazep and EHNA furthermore increased venous adenosine levels by 11 times...
Journal Articles
Subject Area:
Pharmacology
Journal:
Pharmacology
Pharmacology (1988) 36 (5): 331–339.
Published Online: 05 June 2008
.... No difference in adipocyte triglyceride content or mean adipocyte weight between control and caffeine-treated rats was observed. Lipolysis in adipocytes induced by adenosine deaminase (1 U/ml) decreased by 35 % in caffeine-treated rats. This was accompanied by a 2.5-fold increase in the anti-lipolytic potency...
Journal Articles
Subject Area:
Pharmacology
Journal:
Pharmacology
Pharmacology (1977) 15 (1): 84–89.
Published Online: 28 May 2008
...Richard H. Adamson; Daniel W. Zaharevitz; David G. Johns The potent adenosine deaminase inhibitor 2’-deoxycoformycin ((R)-3-(2-deoxy-β-i3-erthyropentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol) inhibits the enzymic inactivation and potentiates the cytotoxic activity of a variety...